Cargando…
TPM3 mediates epithelial-mesenchymal transition in esophageal cancer via MMP2/MMP9
BACKGROUND: Esophageal cancer (EC) is a malignant tumor with high mortality. Correlations have been found between the expression level of tropomyosin 3 (TPM3) and the depth of tumor invasion, lymph node metastasis, and the 5-year survival rate. However, the specific mechanisms underlying EC remain u...
Autores principales: | Chen, Sui, Shen, Zhimin, Gao, Lei, Yu, Shaobin, Zhang, Peipei, Han, Ziyang, Kang, Mingqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422148/ https://www.ncbi.nlm.nih.gov/pubmed/34532475 http://dx.doi.org/10.21037/atm-21-4043 |
Ejemplares similares
-
MiR-107 inhibits the malignant biological behavior of esophageal squamous cell carcinoma by targeting TPM3
por: Zhang, Peipei, et al.
Publicado: (2022) -
IL-1RA inhibits esophageal carcinogenesis and lymphangiogenesis via downregulating VEGF-C and MMP9
por: Shen, Zhimin, et al.
Publicado: (2023) -
Role of MMP-9 in epithelial-mesenchymal transition of thyroid cancer
por: Li, Yuanchun, et al.
Publicado: (2020) -
IL‐1RA suppresses esophageal cancer cell growth by blocking IL‐1α
por: Chen, Sui, et al.
Publicado: (2019) -
Downregulated expression of hepatoma-derived growth factor inhibits migration and invasion of prostate cancer cells by suppressing epithelial-mesenchymal transition and MMP2, MMP9
por: Yang, Feilong, et al.
Publicado: (2018)